Current Perspectives on Statins
Top Cited Papers
- 18 January 2000
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 101 (2) , 207-213
- https://doi.org/10.1161/01.cir.101.2.207
Abstract
—Statins (HMG-CoA reductase inhibitors) are used widely for the treatment of hypercholesterolemia. They inhibit HMG-CoA reductase competitively, reduce LDL levels more than other cholestero...Keywords
This publication has 56 references indexed in Scilit:
- Concomitant use of cytochrome P450 3A4 inhibitors and simvastatinThe American Journal of Cardiology, 1999
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Efficacy and safety of Simvastatin 80 mg/day in hypercholesterolemic patientsThe American Journal of Cardiology, 1998
- Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study) fn1fn1This study was supported by Parke-Davis, Division of Warner Lambert Company, Morris Plains, New Jersey. Manuscript received August 20, 1997; revised manuscript received and accepted November 24, 1997.The American Journal of Cardiology, 1998
- Consensus Statement: Role of Therapy With “Statins” in Patients With HypertriglyceridemiaThe American Journal of Cardiology, 1998
- Geranylgeranylpyrophosphate, a Metabolite of Mevalonate, Regulates the Cell Cycle Progression and DNA Synthesis in Human LymphocytesBiochemical and Biophysical Research Communications, 1997
- Pharmacodynamics and Pharmacokinetics of the HMG-CoA Reductase InhibitorsClinical Pharmacokinetics, 1997
- PravastatinDrugs, 1997
- Myolysis and Acute Renal Failure in a Heart-Transplant Recipient Receiving LovastatinNew England Journal of Medicine, 1988
- Paradoxical Vasoconstriction Induced by Acetylcholine in Atherosclerotic Coronary ArteriesNew England Journal of Medicine, 1986